Journal of Surgical Education
Volume 67, Issue 2 , Pages 99-102 , March 2010

Long-Term Survival with Metastatic Carcinoid Tumors: A Case Report and Review of the Literature

References 

  1. Godwin JD. Carcinoid tumors (An analysis of 2,837 cases). Cancer. 1975;36:560–569
  2. Williams ED, Sandler M. The classification of carcinoid tumours. Lancet. 1963;1:238–239
  3. Zuetenhorst JM, Taal BG. Metastatic carcinoid tumors: a clinical review. Oncologist. 2005;10:123–131
  4. Oberg K, Astrup L, Eriksson B, et al. Nordic NE Tumour Group Guidelines for the management of gastroenteropancreatic neuroendocrine tumours (including bronchopulmonary and thymic neoplasms) (Part I general overview). Acta Oncol. 2004;43:617–625
  5. Modlin IM, Lye KD, Kidd MA. 5-Decade analysis of 13,715 carcinoid tumors. Cancer. 2003;97:934–959
  6. Maggard MA, O'Connell JB, Ko CY. Updated population-based review of carcinoid tumors. Ann Surg. 2004;240:117–122
  7. Bendelow J, Apps E, Jones LE, et al. Carcinoid syndrome. Eur J Surg Oncol. 2008;34:289–296
  8. de Vries H, Verschueren RC, Willemse PH, et al. Diagnostic, surgical and medical aspect of the midgut carcinoids. Cancer Treat Rev. 2002;28:11–25
  9. Soga J, Osaka M, Yakuwa Y. Carcinoids of the ovary: an analysis of 329 reported cases (Exper J Clin). Cancer Res. 2000;19:271–280
  10. Guney N, Sayilgan T, Derin D, et al. Primary carcinoid tumor arising in a mature cystic teratoma of the ovary: A case report. Eur J Gynaecol Oncol. 2009;30:223–225
  11. Robertson RG, Geiger WJ, Davis NB, Ozcan D. Carcinoid tumors. Am Fam Physician. 2006;74:429–434
  12. McStay MK, Caplin ME. Carcinoid tumour. Minerva Med. 2002;93:389–401
  13. Savelli G, Lucignani G, Seregni E, et al. Feasibility of somatostatin receptor scintigraphy in the detection of occult primary gastro-entero-pancreatic (GEP) neuroendocrine tumours. Nucl Med Commun. 2004;25:445–449
  14. Fiebrich HB, Brouwers AH, Koopmans KP, de Vries EG. Combining 6-fluoro-[18F]l-dihydroxyphenylalanine and [18F]fluoro-2-deoxy-d-glucose positron emission tomography for distinction of non-carcinoid malignancies in carcinoid patients. Eur J Cancer. 2009;45:2312–2315
  15. Landry CS, Scoggins CR, McMasters KM, Martin RC. Management of hepatic metastasis of gastrointestinal carcinoid tumors. J Surg Oncol. 2008;97:253–258
  16. O'Toole D, Ducreux M, Bommelaer G, et al. Treatment of carcinoid syndrome: a prospective crossover evaluation of lanreotide versus octreotide in terms of efficacy, patient acceptability, and tolerance. Cancer. 2000;88:770–776
  17. Modlin IM, Moss SF, Chung DC, Jensen RT, Snyderwine E. Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst. 2008;100:1282–1289
  18. Gould SJ. The median isn't the message. Discover. 1985;40–42
  19. Landry CS, Brock G, Scoggins CR, McMasters KM, Martin RC. A proposed staging system for small bowel carcinoid tumors based on an analysis of 6,380 patients. Am J Surg. 2008;196:896–903

PII: S1931-7204(10)00034-6

doi: 10.1016/j.jsurg.2010.02.006

Journal of Surgical Education
Volume 67, Issue 2 , Pages 99-102 , March 2010

Article Tools

* Image Usage & Resolution